BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27285583)

  • 1. The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.
    Lee P; Bhansali R; Izraeli S; Hijiya N; Crispino JD
    Leukemia; 2016 Sep; 30(9):1816-23. PubMed ID: 27285583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.
    Hertzberg L; Vendramini E; Ganmore I; Cazzaniga G; Schmitz M; Chalker J; Shiloh R; Iacobucci I; Shochat C; Zeligson S; Cario G; Stanulla M; Strehl S; Russell LJ; Harrison CJ; Bornhauser B; Yoda A; Rechavi G; Bercovich D; Borkhardt A; Kempski H; te Kronnie G; Bourquin JP; Domany E; Izraeli S
    Blood; 2010 Feb; 115(5):1006-17. PubMed ID: 19965641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients.
    Page EC; Heatley SL; Yeung DT; Thomas PQ; White DL
    Cancer Lett; 2018 Sep; 432():69-74. PubMed ID: 29879498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
    Tigay JH
    J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
    Schwartzman O; Savino AM; Gombert M; Palmi C; Cario G; Schrappe M; Eckert C; von Stackelberg A; Huang JY; Hameiri-Grossman M; Avigad S; Te Kronnie G; Geron I; Birger Y; Rein A; Zarfati G; Fischer U; Mukamel Z; Stanulla M; Biondi A; Cazzaniga G; Vetere A; Wagner BK; Chen Z; Chen SJ; Tanay A; Borkhardt A; Izraeli S
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4030-E4039. PubMed ID: 28461505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute lymphoblastic leukemia of Down Syndrome - Genetics and pathogenesis.
    Izraeli S
    Eur J Med Genet; 2016 Mar; 59(3):158-61. PubMed ID: 26631987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome and acute lymphoblastic leukaemia.
    Whitlock JA
    Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Down syndrome and acute lymphoblastic leukemia].
    Okamoto Y
    Rinsho Ketsueki; 2021; 62(10):1465-1473. PubMed ID: 34732618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doubling up on function: dual-specificity tyrosine-regulated kinase 1A (DYRK1A) in B cell acute lymphoblastic leukemia.
    Kim JH; Li L; Resar LM
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological disorders and leukemia in children with Down syndrome.
    Bruwier A; Chantrain CF
    Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukemias in children with Down syndrome.
    Zwaan CM; Reinhardt D; Hitzler J; Vyas P
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):19-34. PubMed ID: 20113894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review.
    Maloney KW
    Br J Haematol; 2011 Nov; 155(4):420-5. PubMed ID: 21933171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute leukemias in children with Down syndrome.
    Seewald L; Taub JW; Maloney KW; McCabe ER
    Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspicions regarding the genetic inheritance of acute lymphoblastic leukemia in patients with down syndrome.
    Behluli E; Nuhii N; Liehr T; Temaj G
    J Mother Child; 2022 Mar; 26(1):104-110. PubMed ID: 35853737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
    Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
    Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
    Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia.
    Malinge S; Ben-Abdelali R; Settegrana C; Radford-Weiss I; Debre M; Beldjord K; Macintyre EA; Villeval JL; Vainchenker W; Berger R; Bernard OA; Delabesse E; Penard-Lacronique V
    Blood; 2007 Mar; 109(5):2202-4. PubMed ID: 17068151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
    Lundin C; Hjorth L; Behrendtz M; Nordgren A; Palmqvist L; Andersen MK; Biloglav A; Forestier E; Paulsson K; Johansson B
    Genes Chromosomes Cancer; 2012 Feb; 51(2):196-206. PubMed ID: 22072402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.